A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

Condition:   Crohns Disease Intervention:   Drug: Guselkumab Sponsor:   Janssen Pharmaceutical K.K. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials